See other companies on Welcome to the Jungle
Cellares
Cell therapy manufacturing services provider
- 201-500 employees
- Healthcare
- B2B
- Biology
- Social Impact
- The East Side, South San Francisco, CA
Jump to section
Company mission
To accelrete access to life-saving cell therapies.
Our take
There is a significant need for efficient, scalable manufacturing of cell therapies in the biopharmaceutical industry. As demand for advanced treatments like CAR T-cell therapies rises, traditional manufacturing methods often struggle with scalability, high costs, and process failures, limiting patients' access to these lifesaving therapies.
In response, Cellares has developed the CEll Shuttle platform, an automated system designed for high-throughput cell therapy production. The Cell Shuttle can manufacture 16 batches simultaneously, cutting batch costs by up to 50%. By integrating advanced technologies for flow cytometry and cell sorting, Cellares enhances operational efficiency, providing comprehensive solutions that accelerate access to therapies.
Partnering with industry leaders like Kite, Bristol Myers Squibb, and Cabeletta Bio further strengthens its market position, showcasing the platform's potential impact. Along with over $355M in funding and a commercial-scale facility in New Jersey, Cellares is well-prepared to scale operations and meet global demand, positioning itself for future growth in the evolving cell therapy landscape.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Holidays & Flexible Vacation
- Parental Leave
- Comprehensive Healthcare
- 401k + Company Match
- Catered Onsite Meals
- Premium Technology
- EV Charging
- Professional Development
Company values
- Integrity: We honor commitments, communicate openly, and demonstrate the highest ethical standards
- Innovation: We create novel solutions to high-value problems
- Growth Mindset: We value curiosity, the willingness to learn, and the courage to grow beyond ourselves while emrbacing change
- Collaboration: We work as one team, encourage vulnerability & diverse perspectives, and treat each otherwith authenticity & respect
- Passion: We are dedicated to doing meaningful work, achieving exceptional results, and having fun along the journey
- Quality: We are committed to world class Quality in everything we do and build a culture that promotes transparency, ownership, and regulatory compliance based on our customers' needs
Funding (last 2 of 3 rounds)
Aug 2023
$255m
SERIES C
May 2021
$82m
SERIES B
Total funding: $355m
This company has top investors
Leadership
Fabian Gerlinghaus
(Co-Founder & CEO)Graduated from the University of Munich with a Master's Degree in Aerospace Engineering. Prior to co-founding Cellares in 2019, they were the CHief Innovation officer at Synthego.
Articles
Jobs (8)
Data
People, HR, Recruitment
Finance, Legal & Compliance
Other Engineering
Sales & Account Management